Senti Biosciences Inc (SNTI)
Healthcare
Biotechnology
0.34 $
-5.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Senti Biosciences Inc (SNTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -7.5 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14 | -15 | -7.0 | -12 | -8.3 | -7.9 | -14 | -14 | -13 | -9.4 | -6.9 | -7.5 | -37 | |
| 1.2 | 1.8 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 0.9 | 1.5 | -0.2 | 1.5 | 0.7 | 3.4 | |
| 3.4 | 0.4 | 2.1 | 1.3 | -0.8 | 0.7 | 0.6 | 1.2 | 1.5 | 1.6 | 1.4 | 1.3 | 5.8 | |
| 3.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.9 | -0.6 | 6.0 | 0.1 | 2.4 | 3.0 | -1.5 | -2.1 | -1.4 | 7.3 | 0.2 | 1.4 | 7.6 | |
| 3.7 | 1.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.2 | |
| 18 | 21 | – | 0.0 | – | 0.1 | 0.0 | – | -0.2 | 0.0 | 0.0 | 0.1 | -0.1 | |
| 0.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 12,057 | – | -12,056 | -12,056 | – | 0.0 | 0.0 | – | – | – | – | – | – | |
| 0.0 | – | – | – | – | 2.4 | -2.4 | – | – | – | – | – | – | |
| 0.3 | 0.0 | 0.6 | 0.6 | 0.0 | 2.4 | 51 | -0.4 | 1.0 | 0.1 | 11 | -0.1 | 12 | |
| 4.9 | 5.7 | -3.5 | -12 | -8.3 | -5.4 | 38 | -14 | -12 | -9.3 | 4.2 | -7.5 | -25 | |
| -17 | -17 | -7.0 | -12 | -8.3 | -7.9 | -14 | -14 | -13 | -9.4 | -6.9 | -7.5 | -37 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.